Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-08-11 Exercise | 2026-08-13 8:54 pm | N/A 2032-08-04 | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 34,658 | $0 | 471,263 (Direct) | View |
| 2026-08-11 Exercise | 2026-08-13 8:54 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 796 | $159.03 | 471,263 (Direct) | View |
| 2026-08-11 Exercise | 2026-08-13 8:54 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 812 | $194.47 | 471,263 (Direct) | View |
| 2026-08-11 Exercise | 2026-08-13 8:54 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 1,058 | $213.32 | 471,263 (Direct) | View |
| 2026-07-22 Exercise | 2026-07-24 4:51 pm | N/A 2032-08-04 | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 21,697 | $0 | 519,493 (Direct) | View |
| 2026-07-22 Exercise | 2026-07-24 4:51 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 490 | $159.03 | 519,493 (Direct) | View |
| 2026-07-22 Exercise | 2026-07-24 4:51 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 514 | $194.47 | 519,493 (Direct) | View |
| 2026-07-22 Exercise | 2026-07-24 4:51 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 665 | $213.32 | 519,493 (Direct) | View |
| 2026-07-20 Exercise | 2026-07-22 5:03 pm | N/A 2029-06-04 | BeOne Medicines Ltd. | ONC | OYLER JOHN Chief Executive Officer | 441,870 | $0 | 50,493,512 (Direct) | View |
| 2026-07-20 Exercise | 2026-07-22 5:03 pm | N/A N/A | BeOne Medicines Ltd. | ONC | OYLER JOHN Chief Executive Officer | 33,990 | $119.96 | 50,493,512 (Direct) | View |
| 2026-07-17 Exercise | 2026-07-17 5:36 pm | N/A 2029-06-04 | BeOne Medicines Ltd. | ONC | OYLER JOHN Chief Executive Officer | 840,164 | $0 | 51,919,781 (Direct) | View |
| 2026-07-17 Exercise | 2026-07-17 5:36 pm | N/A N/A | BeOne Medicines Ltd. | ONC | OYLER JOHN Chief Executive Officer | 64,628 | $119.96 | 51,919,781 (Direct) | View |
| 2026-07-15 Exercise | 2026-07-17 5:31 pm | N/A 2027-09-26 | BeOne Medicines Ltd. | ONC | OYLER JOHN Chief Executive Officer | 3,681,002 | $0 | 54,014,468 (Direct) | View |
| 2026-07-15 Exercise | 2026-07-17 5:31 pm | N/A N/A | BeOne Medicines Ltd. | ONC | OYLER JOHN Chief Executive Officer | 100,776 | $160.4 | 54,014,468 (Direct) | View |
| 2026-07-15 Exercise | 2026-07-17 5:31 pm | N/A N/A | BeOne Medicines Ltd. | ONC | OYLER JOHN Chief Executive Officer | 76,677 | $169.58 | 54,014,468 (Direct) | View |
| 2026-07-16 Exercise | 2026-07-17 5:31 pm | N/A N/A | BeOne Medicines Ltd. | ONC | OYLER JOHN Chief Executive Officer | 70,096 | $119.96 | 54,014,468 (Direct) | View |
| 2026-07-15 Exercise | 2026-07-17 5:31 pm | N/A N/A | BeOne Medicines Ltd. | ONC | OYLER JOHN Chief Executive Officer | 35,605 | $100.04 | 54,014,468 (Direct) | View |
| 2026-07-14 Exercise | 2026-07-14 9:26 pm | N/A 2026-11-15 | BeOne Medicines Ltd. | ONC | OYLER JOHN Chief Executive Officer | 1,736,800 | $0 | 51,940,777 (Direct) | View |
| 2026-07-14 Exercise | 2026-07-14 9:26 pm | N/A N/A | BeOne Medicines Ltd. | ONC | OYLER JOHN Chief Executive Officer | 97,282 | $36.9 | 51,940,777 (Direct) | View |
| 2026-07-14 Exercise | 2026-07-14 9:26 pm | N/A N/A | BeOne Medicines Ltd. | ONC | OYLER JOHN Chief Executive Officer | 36,318 | $100.04 | 51,940,777 (Direct) | View |
| 2026-07-10 Exercise | 2026-07-14 9:25 pm | N/A 2026-11-15 | BeOne Medicines Ltd. | ONC | OYLER JOHN Chief Executive Officer | 782,834 | $0 | 54,797,396 (Direct) | View |
| 2026-07-10 Exercise | 2026-07-14 9:25 pm | N/A N/A | BeOne Medicines Ltd. | ONC | OYLER JOHN Chief Executive Officer | 60,218 | $36.9 | 54,797,396 (Direct) | View |
| 2026-07-08 Exercise | 2026-07-10 4:44 pm | N/A 2032-08-04 | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 8,632 | $0 | 541,190 (Direct) | View |
| 2026-07-08 Exercise | 2026-07-10 4:44 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 196 | $159.03 | 541,190 (Direct) | View |
| 2026-07-08 Exercise | 2026-07-10 4:44 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 202 | $194.47 | 541,190 (Direct) | View |
| 2026-07-08 Exercise | 2026-07-10 4:44 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 266 | $213.32 | 541,190 (Direct) | View |
| 2026-06-11 Option Award | 2026-06-15 5:55 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Ball Titus B. Principal Accounting Officer | 31,213 | $0 | 0 (Direct) | View |
| 2026-06-11 Option Award | 2026-06-15 5:55 pm | N/A 2036-06-10 | BeOne Medicines Ltd. | ONC | Wang Lai President, Global Head of R&D | 348,400 | $0 | 831,740 (Direct) | View |
| 2026-06-11 Option Award | 2026-06-15 5:55 pm | N/A 2036-06-10 | BeOne Medicines Ltd. | ONC | Rosenberg Aaron Chief Financial Officer | 209,040 | $0 | 137,865 (Direct) | View |
| 2026-06-11 Option Award | 2026-06-15 5:55 pm | N/A 2036-06-10 | BeOne Medicines Ltd. | ONC | Wu Xiaobin President and COO | 348,400 | $0 | 246,140 (Direct) | View |
| 2026-06-11 Option Award | 2026-06-15 5:55 pm | N/A 2036-06-10 | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 132,379 | $0 | 87,308 (Direct) | View |
| 2026-06-11 Option Award | 2026-06-15 5:55 pm | N/A 2036-06-10 | BeOne Medicines Ltd. | ONC | OYLER JOHN Chief Executive Officer | 522,600 | $0 | 46,376,663 (Direct) | View |
| 2026-06-11 Option Award | 2026-06-15 5:54 pm | N/A 2036-06-10 | BeOne Medicines Ltd. | ONC | Wang Xiaodong Chair, Scientific Advisory Brd | 293,384 | $0 | 9,854,198 (Direct) | View |
| 2026-06-11 Option Award | 2026-06-15 5:51 pm | N/A N/A | BeOne Medicines Ltd. | ONC | BRANDICOURT OLIVIER Director | 18,980 | $0 | 46,306 (Direct) | View |
| 2026-06-11 Option Award | 2026-06-15 5:50 pm | N/A N/A | BeOne Medicines Ltd. | ONC | HOOPER ANTHONY C Director | 18,980 | $0 | 83,720 (Direct) | View |
| 2026-06-11 Option Award | 2026-06-15 5:50 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Mooney Elizabeth Fisher Director | 18,980 | $0 | 18,980 (Direct) | View |
| 2026-06-11 Option Award | 2026-06-15 5:50 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Dugan Margaret Director | 18,980 | $0 | 73,164 (Direct) | View |
| 2026-06-11 Option Award | 2026-06-15 5:49 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Sawyers Charles Lazelle Director | 18,980 | $0 | 20,930 (Direct) | View |
| 2026-06-11 Option Award | 2026-06-15 5:49 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Sharp Shalini Director | 18,980 | $0 | 38,125 (Direct) | View |
| 2026-06-11 Option Award | 2026-06-15 5:49 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Riva Alessandro Director | 18,980 | $0 | 73,164 (Direct) | View |
Ownership | 2026-06-15 5:44 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Sawyers Charles Lazelle Director | 0 | $0 | 1,950 (Direct) | View |
| 2026-06-11 Option Award | 2026-06-15 4:38 pm | N/A N/A | BeOne Medicines Ltd. | ONC | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director | 18,980 | $0 | 8,981,441 (Indirect) | View |